Literature DB >> 7728763

The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.

R A Irvine1, M C Yu, R K Ross, G A Coetzee.   

Abstract

The androgen receptor genotype was determined in the white blood cell DNA of 45 African-American, 39 non-Hispanic white, and 39 Asian (Chinese, Japanese) normal subjects and 68 patients with prostate cancer (57 whites), all of whom were residents of Los Angeles County. For each subject, we measured the number of repeats in the polymorphic CAG and GGC microsatellites of exon 1 of the androgen receptor gene. In normal subjects, the distributions of CAG and GGC microsatellites differed significantly among the races (two-sided P = 0.046 and < 0.0005, respectively). The prevalence of short CAG alleles (< 22 repeats) was highest (75%) in African-American males with the highest risk for prostate cancer, intermediate (62%) in intermediate-risk non-Hispanic whites, and lowest (49%) in Asians at very low risk for prostate cancer. High-risk African-Americans also had the lowest frequency (20%) of the GGC allele with 16 repeats; the comparable values for intermediate-risk whites and low-risk Asians were 57% and 70%, respectively. Consistent with the interracial variation in CAG and GGC distributions, there was an excess of white patients with < 22 CAG and not-16 GGC repeats relative to white controls (relative risk, 2.1; one-sided P = 0.08). We observed no association (linkage) between the two microsatellites among normal subjects. On the other hand, there was a statistically significant negative association between the numbers of CAG and GGC repeats among the prostate cancer patients studied (two-sided P = 0.008). Among the 47 subjects with short CAG alleles (< 22 repeats), 43% had long GGC alleles (> 16 repeats) whereas only 15% of the 20 subjects with long CAG alleles (> or = 22 repeats) had long GGC alleles. Overall, our data suggest a possible association between CAG and GGC microsatellites of the androgen receptor gene and prostate cancer development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728763

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  86 in total

Review 1.  Racial differences in the androgen/androgen receptor pathway in prostate cancer.

Authors:  C A Pettaway
Journal:  J Natl Med Assoc       Date:  1999-12       Impact factor: 1.798

2.  A hemizygous short tandem repeat polymorphism 3' to the human phosphoglycerate kinase gene.

Authors:  D E Riley; I R Cho; J N Krieger
Journal:  Mol Biol Rep       Date:  1999-08       Impact factor: 2.316

3.  Molecular analysis of the androgen receptor gene in Hong Kong Chinese infertile men.

Authors:  J Y M Tse; V W S Liu; W S B Yeung; E Y L Lau; E H Y Ng; P C Ho
Journal:  J Assist Reprod Genet       Date:  2003-06       Impact factor: 3.412

4.  Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women.

Authors:  Yoshiji Yamada; Fujiko Ando; Naoakira Niino; Hiroshi Shimokata
Journal:  J Mol Med (Berl)       Date:  2004-11-04       Impact factor: 4.599

5.  South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer.

Authors:  Vijayalakshmi Krishnaswamy; Thangaraj Kumarasamy; Vettriselvi Venkatesan; Sunil Shroff; Vikram R Jayanth; Solomon F D Paul
Journal:  J Hum Genet       Date:  2006-01-26       Impact factor: 3.172

6.  Similar clinical outcomes in African-American and non-African-American males treated with suramin for metastatic prostate cancer.

Authors:  R C Bergan; R G Walls; W D Figg; N A Dawson; D Headlee; A Tompkins; S M Steinberg; E Reed
Journal:  J Natl Med Assoc       Date:  1997-09       Impact factor: 1.798

7.  Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study.

Authors:  Matthew L Freedman; Celeste L Pearce; Kathryn L Penney; Joel N Hirschhorn; Laurence N Kolonel; Brian E Henderson; David Altshuler
Journal:  Am J Hum Genet       Date:  2004-11-29       Impact factor: 11.025

8.  Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?

Authors:  John C Mavropoulos; Alan W Partin; Christopher L Amling; Martha K Terris; Christopher J Kane; William J Aronson; Joseph C Presti; Leslie A Mangold; Stephen J Freedland
Journal:  Urology       Date:  2007-06       Impact factor: 2.649

9.  The androgen receptor's CAG/glutamine tract in mouse models of neurological disease and cancer.

Authors:  Andrew P Lieberman; Diane M Robins
Journal:  J Alzheimers Dis       Date:  2008-06       Impact factor: 4.472

10.  Molecular mechanisms involving prostate cancer racial disparity.

Authors:  David Hatcher; Garrett Daniels; Iman Osman; Peng Lee
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.